Company page

Gilead Sciences, Inc.

Gilead Sciences, Inc. is a publicly traded biotechnology company based in the United States, with a market capitalization of approximately $160.5 billion. The company focuses on discovering, developing, and commercializing innovative medicines in areas such as HIV, liver diseases, oncology, and inflammatory diseases. Gilead is committed to advancing healthcare through its research and development efforts.